Transthyretin: A multifaceted protein

Biomolecular Concepts

Volumn 5, Issue 1, 2014, Pages 45-54

  Vieira, Marta ^a,b   Saraiva, Maria João ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

Alzheimer; amyloid; ischemia; nerve regeneration; nervous system

Indexed keywords

PREALBUMIN; RETINOL BINDING PROTEIN; THYROXINE;

ANIMAL; BLOOD; CEREBROSPINAL FLUID; CHEMISTRY; CHOROID PLEXUS; GENETICS; HUMAN; LIVER; METABOLISM; NEUROLOGIC DISEASE;

ANIMALS; CHOROID PLEXUS; HUMANS; LIVER; NERVOUS SYSTEM DISEASES; PREALBUMIN; RETINOL-BINDING PROTEINS; THYROXINE;

EID: 84896800827     PISSN: 18685021     EISSN: 1868503X     Source Type: Journal    
DOI: 10.1515/bmc-2013-0038     Document Type: Review

References (123)

1. Seibert FB, Nelson JW. Electrophoretic study of the blood protein response in tuberculosis. J Biol Chem 1942; 143: 29-38.
2. Kabat EA, Moore DH, Landow H. An electrophoretic study of the protein components in cerebrospinal fluid and their relationship to the serum proteins. J Clin Invest 1942; 21: 571-7.
3. Ingbar SH. Pre-albumin: a thyroxine binding protein of human plasma. Endocrinology 1958; 63: 256-9.
4. Raz A, Goodman DS. The interaction of thyroxine with human plasma prealbumin and with the prealbumin-retinol-binding protein complex. J Biol Chem 1969; 244: 3230-7.
5. Nomenclature committee of the International Union of Biochemistry (NC-IUB). Enzyme nomenclature. Recommendations 1978. Supplement 2: Corrections and additions. Eur J Biochem 1981; 116: 423-35.
6. Schreiber G, Richardson SJ. The evolution of gene expression, structure and function of transthyretin. Comp Biochem Physiol B Biochem Mol Biol 1997; 116: 137-60. (Pubitemid 27191818)
7. Power DM, Elias NP, Richardson SJ, Mendes J, Soares CM, Santos CR. Evolution of the thyroid hormone-binding protein, transthyretin. Gen Comp Endocrinol 2000; 119: 241-55.
8. Eneqvist T, Lundberg E, Nilsson L, Abagyan R, Sauer-Eriksson AE. The transthyretin-related protein family. Eur J Biochem 2003; 270: 518-32. (Pubitemid 36177318)
9. Blake CC, Swan ID, Rérat C, Berthou J, Laurent A, Rérat B. An X-ray study of the subunit structure of prealbumin. J Mol Biol 1971; 61: 217-24.
10. Kanda Y, Goodman DS, Canfield RE, Morgan FJ. The amino acid sequence of human plasma prealbumin. J Biol Chem 1974; 249: 6796-805.
11. Blake CC, Geisow MJ, Oatley SJ, Rérat B, Rérat C. Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 Å. J Mol Biol 1978; 121: 339-56. (Pubitemid 8361803)
12. Yokoyama T, Mizuguchi M, Nabeshima Y, Kusaka K, Yamada T, Hosoya T, Ohhara T, Kurihara K, Tanaka I, Niimura N. Hydrogen-bond network and pH sensitivity in transthyretin: neutron crystal structure of human transthyretin. J Struct Biol 2012; 177: 283-90.
13. Felding P, Fex G. Cellular origin of prealbumin in the rat. Biochim Biophys Acta 1982; 716: 446-9.
14. Aleshire SL, Bradley CA, Richardson LD, Parl FF. Localization of human prealbumin in choroid plexus epithelium. J Histochem Cytochem 1983; 31: 608-12. (Pubitemid 13041732)
15. Smith FR, Goodman DS. The effects of diseases of the liver, thyroid, and kidneys on the transport of vitamin A in human plasma. J Clin Invest 1971; 50: 2426-36.
16. Stabilini R, Vergani C, Agostoni A, Agostoni RP. Influence of age and sex on prealbumin levels. Clin Chim Acta 1968; 20: 358-9.
17. Vahlquist A, Rask L, Peterson PA, Berg T. The concentrations of retinol-binding protein, prealbumin, and transferrin in the sera of newly delivered mothers and children of various ages. Scand J Clin Lab Invest 1975; 35: 569-75.
18. Ingenbleek Y, De Visscher M. Hormonal and nutritional status: critical conditions for endemic goiter epidemiology? Metabolism 1979; 28: 9-19. (Pubitemid 9118074)
19. Vatassery GT, Quach HT, Smith WE, Benson BA, Eckfeldt JH. A sensitive assay of transthyretin (prealbumin) in human cerebrospinal fluid in nanogram amounts by ELISA. Clin Chim Acta 1991; 197: 19-25.
20. Aldred AR, Brack CM, Schreiber G. The cerebral expression of plasma protein genes in different species. Comp Biochem Physiol B Biochem Mol Biol 1995; 111: 1-15.
21. Schreiber G, Aldred AR, Jaworowski A, Nilsson C, Achen MG, Segal MB. Thyroxine transport from blood to brain via transthyretin synthesis in choroid plexus. Am J Physiol 1990; 258: R338-45. (Pubitemid 20103238)
22. Carro E, Trejo JL, Gomez-Isla T, LeRoith D, Torres-Aleman I. Serum insulin-like growth factor I regulates brain amyloid-beta levels. Nat Med 2002; 8: 1390-7. (Pubitemid 36019424)
23. Stein TD, Johnson JA. Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways. J Neurosci 2002; 22: 7380-8. (Pubitemid 35386337)
24. Buxbaum JN, Ye Z, Reixach N, Friske L, Levy C, Das P, Golde T, Masliah E, Roberts AR, Bartfai T. Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Abeta toxicity. Proc Natl Acad Sci USA 2008; 105: 2681-6. (Pubitemid 351520573)
25. Li X, Masliah E, Reixach N, Buxbaum JN. Neuronal production of transthyretin in human and murine Alzheimer's disease: is it protective? J Neurosci 2011; 31: 12483-90.
26. Sousa JC, Cardoso I, Marques F, Saraiva MJ, Palha JA. Transthyretin and Alzheimer's disease: where in the brain? Neurobiol Aging 2007; 28: 713-8. (Pubitemid 46349354)
27. Pfeffer BA, Becerra SP, Borst DE, Wong P. Expression of transthyretin and retinol binding protein mRNAs and secretion of transthyretin by cultured monkey retinal pigment epithelium. Mol Vis 2004; 10: 23-30. (Pubitemid 38628981)
28. Kato M, Kato K, Blaner WS, Chertow BS, Goodman DS. Plasma and cellular retinoid-binding proteins and transthyretin (prealbumin) are all localized in the islets of Langerhans in the rat. Proc Natl Acad Sci USA 1985; 82: 2488-92. (Pubitemid 15071294)
29. Jacobsson B, Collins VP, Grimelius L, Pettersson T, Sandstedt B, Carlstrom A. Transthyretin immunoreactivity in human and porcine liver, choroid plexus, and pancreatic islets. J Histochem Cytochem 1989; 37: 31-7. (Pubitemid 19016539)
30. Soprano DR, Herbert J, Soprano KJ, Schon EA, Goodman DS. Demonstration of transthyretin mRNA in the brain and other extrahepatic tissues in the rat. J Biol Chem 1985; 260: 11793-8. (Pubitemid 16250842)
31. Soprano DR, Soprano KJ, Goodman DS. Retinol-binding protein and transthyretin mRNA levels in visceral yolk sac and liver during fetal development in the rat. Proc Natl Acad Sci USA 1986; 83: 7330-4. (Pubitemid 16000515)
32. Martone RL, Mizuno R, Herbert J. The mammalian pineal gland is a synthetic site for TTR and RBP. J Rheumatol 1993; 20: 175.
33. McKinnon B, Li H, Richard K, Mortimer R. Synthesis of thyroid hormone binding proteins transthyretin and albumin by human trophoblast. J Clin Endocrinol Metab 2005; 90: 6714-20. (Pubitemid 41759337)
34. Walker AK, Gong Z, Park WM, Zigman JM, Sakata I. Expression of serum retinol binding protein and transthyretin within mouse gastric ghrelin cells. PLoS One 2013; 8: e64882.
35. Socolow EL, Woeber KA, Purdy RH, Holloway MT, Ingbar SH. Preparation of I-131-labeled human serum prealbumin and its metabolism in normal and sick patients. J Clin Invest 1965; 44: 1600-9.
36. Vahlquist A. Metabolism of the vitamin-A-transporting protein complex: turnover of retinol-binding protein, prealbumin and vitamin A in a primate (Macaca Irus). Scand J Clin Lab Invest 1972; 30: 349-60.
37. Dickson PW, Howlett GJ, Schreiber G. Metabolism of prealbumin in rats and changes induced by acute inflammation. Eur J Biochem 1982; 129: 289-93. (Pubitemid 13153725)
38. Makover A, Moriwaki H, Ramakrishnan R, Saraiva MJ, Blaner WS, Goodman DS. Plasma transthyretin. Tissue sites of degradation and turnover in the rat. J Biol Chem 1988; 263: 8598-603.
39. Sousa MM, Norden AG, Jacobsen C, Willnow TE, Christensen EI, Thakker RV, Verroust PJ, Moestrup SK, Saraiva MJ. Evidence for the role of megalin in renal uptake of transthyretin. J Biol Chem 2000; 275: 38176-81. (Pubitemid 32009135)
40. Sousa MM, Saraiva MJ. Internalization of transthyretin. Evidence of a novel yet unidentified receptor-associated protein (RAP)-sensitive receptor. J Biol Chem 2001; 276: 14420-5.
41. Mortimer RH, Landers KA, Balakrishnan B, Li H, Mitchell MD, Patel J, Richard K. Secretion and transfer of the thyroid hormone binding protein transthyretin by human placenta. Placenta 2012; 33: 252-6.
42. Landers KA, McKinnon BD, Li H, Subramaniam VN, Mortimer RH, Richard K. Carrier-mediated thyroid hormone transport into placenta by placental transthyretin. J Clin Endocrinol Metab 2009; 94: 2610-6.
43. Bernal J. Thyroid hormones and brain development. Vitam Horm 2005; 71: 95-122. (Pubitemid 43589035)
44. Cheng SY, Leonard JL, Davis PJ. Molecular aspects of thyroid hormone actions. Endocr Rev 2010; 31: 139-70.
45. Loun B, Hage DS. Characterization of thyroxine-albumin binding using high-performance affinity chromatography. I. Interactions at the warfarin and indole sites of albumin. J Chromatogr 1992; 579: 225-35.
46. Bartalena L. Recent achievements in studies on thyroid hormone-binding proteins. Endocr Rev 1990; 11: 47-64. (Pubitemid 20101336)
47. Hagen GA, Solberg LA, Jr. Brain and cerebrospinal fluid permeability to intravenous thyroid hormones. Endocrinology 1974; 95: 1398-410.
48. Chanoine JP, Braverman LE. The role of transthyretin in the transport of thyroid hormone to cerebrospinal fluid and brain. Acta Med Austriaca 1992; 19 Suppl 1:25-8.
49. Blake CC, Geisow MJ, Swan ID, Rerat C, Rerat B. Structure of human plasma prealbumin at 2-5 Å resolution. A preliminary report on the polypeptide chain conformation, quaternary structure and thyroxine binding. J Mol Biol 1974; 88: 1-12.
50. Andrea TA, Cavalieri RR, Goldfine ID, Jorgensen EC. Binding of thyroid hormones and analogues to the human plasma protein prealbumin. Biochemistry 1980; 19: 55-63. (Pubitemid 10154185)
51. Mendel CM. The free hormone hypothesis: a physiologically based mathematical model. Endocr Rev 1989; 10: 232-74. (Pubitemid 19223060)
52. Palha JA, Nissanov J, Fernandes R, Sousa JC, Bertrand L, Dratman MB, Morreale de Escobar G, Gottesman M, Saraiva MJ. Thyroid hormone distribution in the mouse brain: the role of transthyretin. Neuroscience 2002; 113: 837-47. (Pubitemid 35245253)
53. Episkopou V, Maeda S, Nishiguchi S, Shimada K, Gaitanaris GA, Gottesman ME, Robertson EJ. Disruption of the transthyretin gene results in mice with depressed levels of plasma retinol and thyroid hormone. Proc Natl Acad Sci USA 1993; 90: 2375-9. (Pubitemid 23078629)
54. Palha JA, Episkopou V, Maeda S, Shimada K, Gottesman ME, Saraiva MJ. Thyroid hormone metabolism in a transthyretin-null mouse strain. J Biol Chem 1994; 269: 33135-9.
55. Sousa JC, de Escobar GM, Oliveira P, Saraiva MJ, Palha JA. Transthyretin is not necessary for thyroid hormone metabolism in conditions of increased hormone demand. J Endocrinol 2005; 187: 257-66. (Pubitemid 41685185)
56. Mendel CM, Murai JT, Siiter PK, Monroe SE, Inoue M. Conservation of free but not total or non-sex-hormone-binding-globulin-bound testosterone in serum from Nagase analbuminemic rats. Endocrinology 1989; 124(6): 3128-30. (Pubitemid 19154157)
57. Refetoff S. Inherited thyroxine-binding globulin abnormalities in man. Endocr Rev 1989; 10: 275-93. (Pubitemid 19223061)
58. Bartalena L, Robbins J. Thyroid hormone transport proteins. Clin Lab Med 1993; 13: 583-98. (Pubitemid 23267628)
59. Patel J, Landers K, Li H, Mortimer RH, Richard K. Delivery of maternal thyroid hormones to the fetus. Trends Endocrinol Metab 2011; 22: 164-70.
60. Gudas LJ. Emerging roles for retinoids in regeneration and differentiation in normal and disease states. Biochim Biophys Acta 2012; 1821: 213-21.
61. Shearer KD, Stoney PN, Morgan PJ, McCaffery PJ. A vitamin for the brain. Trends Neurosci 2012; 35: 733-41.
62. Lerner AJ, Gustaw-Rothenberg K, Smyth S, Casadesus G. Retinoids for treatment of Alzheimer's disease. Biofactors 2012; 38: 84-9.
63. Corcoran JP, So PL, Maden M. Disruption of the retinoid signalling pathway causes a deposition of amyloid beta in the adult rat brain. Eur J Neurosci 2004; 20: 896-902. (Pubitemid 39141297)
64. Ono K, Yoshiike Y, Takashima A, Hasegawa K, Naiki H, Yamada M. Vitamin A exhibits potent antiamyloidogenic and fibril-destabilizing effects in vitro. Exp Neurol 2004; 189: 380-92. (Pubitemid 39221830)
65. Ono K, Yamada M. Vitamin A and Alzheimer's disease. Geriatr Gerontol Int 2012; 12: 180-8.
66. Kanai M, Raz A, Goodman DS. Retinol-binding protein: the transport protein for vitamin A in human plasma. J Clin Invest 1968; 47: 2025-44.
67. Goodman DS. Vitamin A and retinoids in health and disease. N Engl J Med 1984; 310: 1023-31. (Pubitemid 14129236)
68. Noy N, Slosberg E, Scarlata S. Interactions of retinol with binding proteins: studies with retinol-binding protein and with transthyretin. Biochemistry 1992; 31: 11118-24.
69. Monaco HL, Rizzi M, Coda A. Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein. Science 1995; 268: 1039-41.
70. van Bennekum AM, Wei S, Gamble MV, Vogel S, Piantedosi R, Gottesman M, Episkopou V, Blaner WS. Biochemical basis for depressed serum retinol levels in transthyretin-deficient mice. J Biol Chem 2001; 276: 1107-13. (Pubitemid 32096534)
71. Wei S, Episkopou V, Piantedosi R, Maeda S, Shimada K, Gottesman ME, Blaner WS. Studies on the metabolism of retinol and retinol-binding protein in transthyretin-deficient mice produced by homologous recombination. J Biol Chem 1995; 270: 866-70.
72. Sundaram M, Sivaprasadarao A, DeSousa MM, Findlay JB. The transfer of retinol from serum retinol-binding protein to cellular retinol-binding protein is mediated by a membrane receptor. J Biol Chem 1998; 273: 3336-42. (Pubitemid 28109748)
73. Kawaguchi R, Yu J, Honda J, Hu J, Whitelegge J, Ping P, Wiita P, Bok D, Sun H. A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A. Science 2007; 315: 820-5.
74. Alapatt P, Guo F, Komanetsky SM, Wang S, Cai J, Sargsyan A, Rodriguez Diaz E, Bacon BT, Aryal P, Graham TE. Liver retinol transporter and receptor for serum retinol-binding protein (RBP4). J Biol Chem 2013; 288: 1250-65.
75. Sousa MM, Berglund L, Saraiva MJ. Transthyretin in high density lipoproteins: association with apolipoprotein A-I. J Lipid Res 2000; 41: 58-65. (Pubitemid 30051842)
76. Liz MA, Faro CJ, Saraiva MJ, Sousa MM. Transthyretin, a new cryptic protease. J Biol Chem 2004; 279: 21431-8. (Pubitemid 38656553)
77. Liz MA, Gomes CM, Saraiva MJ, Sousa MM. ApoA-I cleaved by transthyretin has reduced ability to promote cholesterol efflux and increased amyloidogenicity. J Lipid Res 2007; 48: 2385-95. (Pubitemid 350058750)
78. Liz MA, Fleming CE, Nunes AF, Almeida MR, Mar FM, Choe Y, Craik CS, Powers JC, Bogyo M, Sousa MM. Substrate specificity of transthyretin: identification of natural substrates in the nervous system. Biochem J 2009; 419: 467-74.
79. Costa R, Ferreira-da-Silva F, Saraiva MJ, Cardoso I. Transthyretin protects against A-beta peptide toxicity by proteolytic cleavage of the peptide: a mechanism sensitive to the Kunitz protease inhibitor. PLoS One 2008; 3:e2899.
80. Sousa JC, Grandela C, Fernandez-Ruiz J, de Miguel R, de Sousa L, Magalhaes AI, Saraiva MJ, Sousa N, Palha JA. Transthyretin is involved in depression-like behaviour and exploratory activity. J Neurochem 2004; 88: 1052-8. (Pubitemid 38280673)
81. Prigge ST, Mains RE, Eipper BA, Amzel LM. New insights into copper monooxygenases and peptide amidation: structure, mechanism and function. Cell Mol Life Sci 2000; 57: 1236-59. (Pubitemid 30663481)
82. Nunes AF, Saraiva MJ, Sousa MM. Transthyretin knockouts are a new mouse model for increased neuropeptide Y. FASEB J 2006; 20: 166-8. (Pubitemid 43100502)
83. Sousa JC, Marques F, Dias-Ferreira E, Cerqueira JJ, Sousa N, Palha JA. Transthyretin influences spatial reference memory. Neurobiol Learn Mem 2007; 88: 381-5. (Pubitemid 47321223)
84. Brouillette J, Quirion R. Transthyretin: a key gene involved in the maintenance of memory capacities during aging. Neurobiol Aging 2008; 29: 1721-32.
85. Fleming CE, Saraiva MJ, Sousa MM. Transthyretin enhances nerve regeneration. J Neurochem 2007; 103: 831-9. (Pubitemid 47498041)
86. Fleming CE, Mar FM, Franquinho F, Saraiva MJ, Sousa MM. Transthyretin internalization by sensory neurons is megalin mediated and necessary for its neuritogenic activity. J Neurosci 2009; 29: 3220-32.
87. Dekki N, Refai E, Holmberg R, Kohler M, Jornvall H, Berggren PO, Juntti-Berggren L. Transthyretin binds to glucose-regulated proteins and is subjected to endocytosis by the pancreatic beta-cell. Cell Mol Life Sci 2012; 69: 1733-43.
88. Refai E, Dekki N, Yang SN, Imreh G, Cabrera O, Yu L, Yang G, Norgren S, Rossner SM, Inverardi L, Ricordi C, Olivecrona G, Andersson M, Jornvall H, Berggren PO, Juntti-Berggren L. Transthyretin constitutes a functional component in pancreatic beta-cell stimulus-secretion coupling. Proc Natl Acad Sci USA 2005; 102: 17020-5. (Pubitemid 41692676)
89. Vieira M, Saraiva MJ. Transthyretin regulates hippocampal 14-3-3zeta protein levels. FEBS Lett 2013; 587: 1482-8.
90. Nunes AF, Montero M, Franquinho F, Santos SD, Malva J, Zimmer J, Sousa MM. Transthyretin knockout mice display decreased susceptibility to AMPA-induced neurodegeneration. Neurochem Int 2009; 55: 454-7.
91. Zerr I, Bodemer M, Gefeller O, Otto M, Poser S, Wiltfang J, Windl O, Kretzschmar HA, Weber T. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol 1998; 43: 32-40. (Pubitemid 28124646)
92. Gloeckner SF, Meyne F, Wagner F, Heinemann U, Krasnianski A, Meissner B, Zerr I. Quantitative analysis of transthyretin, tau and amyloid-beta in patients with dementia. J Alzheimers Dis 2008; 14: 17-25. (Pubitemid 352039015)
93. Zhang HL, Zhang XM, Mao XJ, Deng H, Li HF, Press R, Fredrikson S, Zhu J. Altered cerebrospinal fluid index of prealbumin, fibrinogen, and haptoglobin in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy. Acta Neurol Scand 2012; 125: 129-35.
94. Ruetschi U, Zetterberg H, Podust VN, Gottfries J, Li S, Hviid Simonsen A, McGuire J, Karlsson M, Rymo L, Davies H, Minthon L, Blennow K. Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF. Exp Neurol 2005; 196: 273-81. (Pubitemid 41607815)
95. Brettschneider J, Lehmensiek V, Mogel H, Pfeifle M, Dorst J, Hendrich C, Ludolph AC, Tumani H. Proteome analysis reveals candidate markers of disease progression in amyotrophic lateral sclerosis (ALS). Neurosci Lett 2010; 468: 23-7.
96. Arguelles S, Venero JL, Garcia-Rodriguez S, Tomas-Camardiel M, Ayala A, Cano J, Machado A. Use of haptoglobin and transthyretin as potential biomarkers for the preclinical diagnosis of Parkinson's disease. Neurochem Int 2010; 57: 227-34.
97. Chen R, Vendrell I, Chen CP, Cash D, O'Toole KG, Williams SA, Jones C, Preston JE, Wheeler JX. Proteomic analysis of rat plasma following transient focal cerebral ischemia. Biomark Med 2011; 5: 837-46.
98. Suzuyama K, Shiraishi T, Oishi T, Ueda S, Okamoto H, Furuta M, Mineta T, Tabuchi K. Combined proteomic approach with SELDI-TOF-MS and peptide mass fingerprinting identified the rapid increase of monomeric transthyretin in rat cerebrospinal fluid after transient focal cerebral ischemia. Brain Res Mol Brain Res 2004; 129: 44-53. (Pubitemid 39304248)
99. Liverman CS, Cui L, Yong C, Choudhuri R, Klein RM, Welch KM, Berman NE. Response of the brain to oligemia: gene expression, c-Fos, and Nrf2 localization. Brain Res Mol Brain Res 2004; 126: 57-66. (Pubitemid 38781164)
100. Santos SD, Lambertsen KL, Clausen BH, Akinc A, Alvarez R, Finsen B, Saraiva MJ. CSF transthyretin neuroprotection in a mouse model of brain ischemia. J Neurochem 2010; 115: 1434-44.
101. Hornstrup LS, Frikke-Schmidt R, Nordestgaard BG, Tybjaerg-Hansen A. Genetic stabilization of transthyretin, cerebrovascu-lar disease, and life expectancy. Arterioscler Thromb Vasc Biol 2013; 33: 1441-7.
102. Goedert M, Spillantini MG. A century of Alzheimer's disease. Science 2006; 314: 777-81. (Pubitemid 44706636)
103. Elovaara I, Maury CP, Palo J. Serum amyloid A protein, albumin and prealbumin in Alzheimer's disease and in demented patients with Down's syndrome. Acta Neurol Scand 1986; 74: 245-50. (Pubitemid 17174823)
104. Castano EM, Roher AE, Esh CL, Kokjohn TA, Beach T. Comparative proteomics of cerebrospinal fluid in neuropathologically-confrmed Alzheimer's disease and non-demented elderly subjects. Neurol Res 2006; 28: 155-63.
105. Han SH, Jung ES, Sohn JH, Hong HJ, Hong HS, Kim JW, Na DL, Kim M, Kim H, Ha HJ, Kim YH, Huh N, Jung MW, Mook-Jung I. Human serum transthyretin levels correlate inversely with Alzheimer's disease. J Alzheimers Dis 2011; 25: 77-84.
106. Ribeiro CA, Santana I, Oliveira C, Baldeiras I, Moreira J, Saraiva MJ, Cardoso I. Transthyretin decrease in plasma of MCI and AD patients: investigation of mechanisms for disease modulation. Curr Alzheimer Res 2012; 9: 881-9.
107. Schwarzman AL, Gregori L, Vitek MP, Lyubski S, Strittmatter WJ, Enghilde JJ, Bhasin R, Silverman J, Weisgraber KH, Coyle PK, Zagorski MG, Tafous J, Eisenberg M, Saunders AM, Roses AD, Goldgaber D. Transthyretin sequesters amyloid beta protein and prevents amyloid formation. Proc Natl Acad Sci USA 1994; 91: 8368-72. (Pubitemid 24273665)
108. Liu L, Murphy RM. Kinetics of inhibition of beta-amyloid aggregation by transthyretin. Biochemistry 2006; 45: 15702-9. (Pubitemid 46032490)
109. Lazarov O, Robinson J, Tang Y P, Hairston IS, Korade-Mirnics Z, Lee VM, Hersh LB, Sapolsky RM, Mirnics K, Sisodia SS. Environmental enrichment reduces Aβ levels and amyloid deposition in transgenic mice. Cell 2005; 120: 701-13. (Pubitemid 40343081)
110. Choi SH, Leight SN, Lee VM, Li T, Wong PC, Johnson JA, Saraiva MJ, Sisodia SS. Accelerated Abeta deposition in APPswe/PS1ΔE9 mice with hemizygous deletions of TTR (transthyretin). J Neurosci 2007; 27: 7006-10. (Pubitemid 47015887)
111. Oliveira SM, Ribeiro CA, Cardoso I, Saraiva MJ. Gender-dependent transthyretin modulation of brain amyloid-beta levels: evidence from a mouse model of Alzheimer's disease. J Alzheimers Dis 2011; 27: 429-39.
112. Wati H, Kawarabayashi T, Matsubara E, Kasai A, Hirasawa T, Kubota T, Harigaya Y, Shoji M, Maeda S. Transthyretin accelerates vascular Abeta deposition in a mouse model of Alzheimer's disease. Brain Pathol 2009; 19: 48-57.
113. Doggui S, Brouillette J, Chabot JG, Farso M, Quirion R. Possible involvement of transthyretin in hippocampal β-amyloid burden and learning behaviors in a mouse model of Alzheimer's disease (TgCRND8). Neurodegener Dis 2010; 7: 88-95.
114. Ribeiro CA, Oliveira SM, Guido LF, Magalhaes A, Valencia G, Arsequell G, Saraiva MJ, Cardoso I. Transthyretin stabilization by iododiflunisal promotes amyloid-β peptide clearance, decreases its deposition, and ameliorates cognitive defcits in an Alzheimer's disease mouse model. J Alzheimers Dis 2014; 39(2): 357-70.
115. Andrade C. A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 1952; 75: 408-27.
116. Dyck PJ, Lambert EH. Dissociated sensation in amylidosis. Compound action potential, quantitative histologic and teased-fber, and electron microscopic studies of sural nerve biopsies. Arch Neurol 1969; 20: 490-507.
117. Sousa MM, Saraiva MJ. Neurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signaling. Prog Neurobiol 2003; 71: 385-400. (Pubitemid 38125193)
118. Coelho T, Maurer MS, Suhr OB. THAOS-The transthyretin am-yloidosis outcomes survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis. Curr Med Res Opin 2013; 29: 63-76.
119. Sekijima Y, Yoshida K, Tokuda T, Ikeda S. Familial Transthyretin Amyloidosis. 2001 [updated January 26, 2012]; Available from: http://www.ncbi.nlm.nih.gov/books/NBK1194/.
120. Jacobson DR, Pastore RD, Yaghoubian R, Kane I, Gallo G, Buck FS, Buxbaum JN. Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans. N Engl J Med 1997; 336: 466-73. (Pubitemid 27074357)
121. Westermark P, Sletten K, Johansson B, Cornwell GG, 3rd. Fibril in senile systemic amyloidosis is derived from normal trans-thyretin. Proc Natl Acad Sci USA 1990; 87: 2843-5.
122. Kalkunte SS, Neubeck S, Norris WE, Cheng SB, Kostadinov S, Vu Hoang D, Ahmed A, von Eggeling F, Shaikh Z, Padbury J, Berg G, Olofsson A, Markert UR, Sharma S. Transthyretin is dysregulated in pre eclampsia, and its native form prevents the onset of disease in a preclinical mouse model. Am J Pathol 2013; 183: 1425-36.
123. Quintas A, Vaz DC, Cardoso I, Saraiva MJ, Brito RM. Tetramer dissociation and monomer partial unfolding precedes protof-bril formation in amyloidogenic transthyretin variants. J Biol Chem 2001; 276: 27207-13.